Telix Pharmaceuticals (T3X.F) Q1 2026 Earnings

19FebConfirmed
Q4 2024
Q1 2025
Q3 2025
Q1 2026
-0.01
0.03
0.07
0.11

Details

Expected EPS
0.0278290131
Actual EPS
-0.00985188
Surprise EPS
-0.04
Surprise Percent
+135.4%

Description

Telix Pharmaceuticals (T3X.F) has reported earnings of -0.00985188 per share for Q1 2026.

0 Comments

Share your thoughts